A New Strategy to Fight Metallodrug Resistance: Mitochondria‐Relevant Treatment through Mitophagy to Inhibit Metabolic Adaptations of Cancer Cells
Authors:
- 5 May 2022
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 61 (27) , e202203843
Abstract
Metabolic adaptations can help cancer cells to escape from chemotherapeutics, mainly involving autophagy and ATP production. Herein, we report a new rhein‐based cyclometalated IrIII complex, Ir‐Rhein, that can accurately target mitochondria and effectively inhibit metabolic adaptations. The complex Ir‐Rhein induces severe mitochondrial damage and initiates mitophagy to reduce the number of mitochondria and subsequently inhibit both mitochondrial and glycolytic bioenergetics, which eventually leads to ATP starvation death. Moreover, Ir‐Rhein can overcome cisplatin resistance. Co‐incubation experiment, 3D tumor spheroids experiment and transcriptome analysis reveal that Ir‐Rhein shows promising antiproliferation performance for cisplatin‐resistant cancer cells with the regulation of platinum resistance‐related transporters. To our knowledge, this is a new strategy to overcome metallodrug resistance with a mitochondria‐relevant treatment.Keywords
Funding Information
- National Natural Science Foundation of China (21977052, 220770066)
This publication has 58 references indexed in Scilit:
- The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegenerationCellular Signalling, 2014
- A bioenergetic profile of non-transformed fibroblasts uncovers a link between death-resistance and enhanced spare respiratory capacityMitochondrion, 2013
- Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancerBiomaterials, 2013
- Novel monofunctional platinum (II) complex Mono-Pt induces apoptosis-independent autophagic cell death in human ovarian carcinoma cells, distinct from cisplatinAutophagy, 2013
- Mechanisms and insights into drug resistance in cancerFrontiers in Pharmacology, 2013
- How cancer metabolism is tuned for proliferation and vulnerable to disruptionNature, 2012
- Mitochondria and cancerNature Reviews Cancer, 2012
- A Nonemissive Iridium(III) Complex That Specifically Lights-Up the Nuclei of Living CellsJournal of the American Chemical Society, 2011
- ABC transporters in cancer: more than just drug efflux pumpsNature Reviews Cancer, 2010
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007